한빛사논문
- 조회729
Kijung Kwak1, Bo Yu1, Robert J. Lewandowski1, Dong-Hyun Kim1,2,3,4
1. Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
2. Department of Biomedical Engineering, McCormick School of Engineering, Evanston, IL 60208, USA.
3. Robert H. Lurie Comprehensive Cancer Center, Chicago, IL 60611, USA.
4. Department of Bioengineering, University of Illinois at Chicago, Chicago, IL 60607, USA.
Corresponding author: Prof. Dong-Hyun Kim
Abstract
With rapid advances in modern imaging, minimally invasive ablative procedures have emerged as popular alternatives to surgical removal of tumors. Tumor ablation modalities currently offered in clinical practice include microwave ablation, radiofrequency ablation, cryoablation, high-intensity focused ultrasound, and irreversible electroporation. Cryoablation, a non-heat-based method of ablation, is increasingly being used for treating various solid tumors. Accumulated comparative data of cryoablation versus heat-based ablation techniques (e.g., radiofrequency and microwave ablation) shows superior tumor response and quicker recovery time. Evolving research has demonstrated that nanocarriers may serves as excellent catalysts for the cryoablation therapy, imaging guidance, and the co-delivery of therapeutics for minimally invasive, precise, and complete treatment of cancer with immune modulation. This review article focuses on the current status of cryoablation in clinical practice, considers opportunities for enhancing therapeutic outcomes from cryoablation, and discusses new research in the field, including theranostic nanoparticles-mediated cryotherapy and combinational cryo-based immunotherapies.
논문정보
- Review Paper
- 2022년 02월 (BRIC 등록일 2022-03-02)
- 국외 연구진
- 바이오·의료융합 > 바이오센싱 및 나노바이오물질
댓글 작성 로그인
팝업 닫기관련 링크
연구자 키워드
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기
